Metoclopramida en el paciente crítico
- 9 March 2017
- journal article
- other
- Published by Elsevier in Acta Colombiana de Cuidado Intensivo
- Vol. 17 (2) , 129-132
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Review article: metoclopramide and tardive dyskinesiaAlimentary Pharmacology & Therapeutics, 2009
- Prokinetic therapy for feed intolerance in critical illness: One drug or two?Critical Care Medicine, 2007
- Risk of Clostridium difficile diarrhoea in critically ill patients treated with erythromycin-based prokinetic therapy for feed intoleranceIntensive Care Medicine, 2007
- The use of erythromycin as a gastrointestinal prokinetic agent in adult critical care: benefits versus risksJournal of Antimicrobial Chemotherapy, 2007
- Erythromycin is more effective than metoclopramide in the treatment of feed intolerance in critical illness*Critical Care Medicine, 2007
- Erythromycin for prokinesis: imprudent prescribing?Critical Care, 2006
- Rate of metoclopramide infusion affects the severity and incidence of akathisiaEmergency Medicine Journal, 2005
- Erythromycin dose of 70 mg accelerates gastric emptying as effectively as 200 mg in the critically illIntensive Care Medicine, 2005
- Tardive Dyskinesia Risks and Metoclopramide Use Before and After U.S. Market Withdrawal of CisaprideJournal of the American Pharmacists Association, 2004
- Extrapyramidal reactions with metoclopramide.BMJ, 1985